GJA1 and breast carcinoma: Such a Cx43 expression profile has already been demonstrated in bone metastatic breast cancer cells [32], but in this context Cx43 was considered as an osteoblastic differentiation marker reflecting an osteomimetic phenotype for cancer cells more than an active factor of metastatic acquisition.